Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Febrile neutropenia? 8,844 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8,844 reports of Febrile neutropenia have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 10.7% of all adverse event reports for DOXORUBICIN.

8,844
Reports of Febrile neutropenia with DOXORUBICIN
10.7%
of all DOXORUBICIN reports
1,075
Deaths
5,491
Hospitalizations

How Dangerous Is Febrile neutropenia From DOXORUBICIN?

Of the 8,844 reports, 1,075 (12.2%) resulted in death, 5,491 (62.1%) required hospitalization, and 1,290 (14.6%) were considered life-threatening.

Is Febrile neutropenia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 8,844 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925) Sepsis (2,740)

What Other Drugs Cause Febrile neutropenia?

CYCLOPHOSPHAMIDE (11,318) VINCRISTINE (8,676) RITUXIMAB (6,382) CYTARABINE (6,142) METHOTREXATE (6,091) ETOPOSIDE (5,966) CARBOPLATIN (4,888) DEXAMETHASONE (4,382) PREDNISONE (3,956) CISPLATIN (3,010)

Which DOXORUBICIN Alternatives Have Lower Febrile neutropenia Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Febrile neutropenia Reports All Drugs Causing Febrile neutropenia DOXORUBICIN Demographics